Tolerability of treatment with pirfenidone or nintedanib for pulmonary fibrosis in the real world

被引：4

作者：

Ogura, Takashi ^{[1
]}

Kitamura, Hideya ^{[1
]}

机构：

[1] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan

来源：

RESPIROLOGY | 2017年 / 22卷 / 06期

关键词：

idiopathic pulmonary fibrosis; nintedanib; pirfenidone; therapeutics; tolerability; RANDOMIZED-TRIALS; SAFETY;

D O I：

10.1111/resp.13059

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：1051 / 1052

页数：2

共 9 条

[1] Nintedanib in Japanese patients with idiopathic pulmonary fibrosis: A subgroup analysis of the INPULSIS® randomized trials [J].

Azuma, Arata ;

Taniguchi, Hiroyuki ;

Inoue, Yoshikazu ;

Kondoh, Yasuhiro ;

Ogura, Takashi ;

Homma, Sakae ;

Fujimoto, Tsuyoshi ;

Sakamoto, Wataru ;

Sugiyama, Yukihiko ;

Nukiwa, Toshihiro .

RESPIROLOGY, 2017, 22 (04) :750-757

[2] Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis [J].

Corte, Tamera ;

Bonella, Francesco ;

Crestani, Bruno ;

Demedts, Maurits G. ;

Richeldi, Luca ;

Coeck, Carl ;

Pelling, Katy ;

Quaresma, Manuel ;

Lasky, Joseph A. .

RESPIRATORY RESEARCH, 2015, 16

[3] Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions [J].

Galli, Jonathan A. ;

Pandya, Aloknath ;

Vega-Olivo, Michelle ;

Dass, Chandra ;

Zhao, Huaqing ;

Criner, Gerard J. .

RESPIROLOGY, 2017, 22 (06) :1171-1178

[4] Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis [J].

Hughes, Gareth ;

Toellner, Hannah ;

Morris, Helen ;

Leonard, Colm ;

Chaudhuri, Nazia .

JOURNAL OF CLINICAL MEDICINE, 2016, 5 (09)

[5]

Ikeda S, 2017, RESPIR INVESTIG, V55, P51, DOI 10.1016/j.resinv.2016.08.003

[6] A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis [J].

King, Talmadge E., Jr. ;

Bradford, Williamson Z. ;

Castro-Bernardini, Socorro ;

Fagan, Elizabeth A. ;

Glaspole, Ian ;

Glassberg, Marilyn K. ;

Gorina, Eduard ;

Hopkins, Peter M. ;

Kardatzke, David ;

Lancaster, Lisa ;

Lederer, David J. ;

Nathan, Steven D. ;

Pereira, Carlos A. ;

Sahn, Steven A. ;

Sussman, Robert ;

Swigris, Jeffrey J. ;

Noble, Paul W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2083-2092

[7] Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials [J].

Noble, Paul W. ;

Albera, Carlo ;

Bradford, Williamson Z. ;

Costabel, Ulrich ;

Glassberg, Marilyn K. ;

Kardatzke, David ;

King, Talmadge E., Jr. ;

Lancaster, Lisa ;

Sahn, Steven A. ;

Szwarcberg, Javier ;

Valeyre, Dominique ;

du Bois, Roland M. .

LANCET, 2011, 377 (9779) :1760-1769

[8] All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis [J].

Ogura, Takashi ;

Azuma, Arata ;

Inoue, Yoshikazu ;

Taniguchi, Hiroyuki ;

Chida, Kingo ;

Bando, Masashi ;

Niimi, Yuka ;

Kakutani, Shinichi ;

Suga, Moritaka ;

Sugiyama, Yukihiko ;

Kudoh, Shoji ;

Nukiwa, Toshihiro .

RESPIRATORY INVESTIGATION, 2015, 53 (05) :232-241

[9] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis [J].

Richeldi, Luca ;

du Bois, Roland M. ;

Raghu, Ganesh ;

Azuma, Arata ;

Brown, Kevin K. ;

Costabel, Ulrich ;

Cottin, Vincent ;

Flaherty, Kevin R. ;

Hansell, David M. ;

Inoue, Yoshikazu ;

Kim, Dong Soon ;

Kolb, Martin ;

Nicholson, Andrew G. ;

Noble, Paul W. ;

Selman, Moises ;

Taniguchi, Hiroyuki ;

Brun, Michele ;

Le Maulf, Florence ;

Girard, Mannaig ;

Stowasser, Susanne ;

Schlenker-Herceg, Rozsa ;

Disse, Bernd ;

Collard, Harold R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2071-2082

← 1 →